Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58101-23-8

Post Buying Request

58101-23-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58101-23-8 Usage

General Description

Ethyl 2,4-difluorobenzoylacetate is a chemical compound with the molecular formula C11H11F2O3. It is a synthetic organic compound that is commonly used in the field of pharmaceuticals and agrochemicals. ETHYL 2,4-DIFLUOROBENZOYLACETATE is commonly used as an intermediate in the synthesis of various pharmaceutical compounds and is also utilized as a building block for the synthesis of agrochemicals. It is a colorless liquid with a mildly sweet aroma and is typically stored and handled in a controlled environment due to its flammability and potential health hazards. The compound is also known by the trade names of 2,4-Difluorobenzoylacetate ethyl ester and ethyl 2,4-difluorophenylglyoxylate.

Check Digit Verification of cas no

The CAS Registry Mumber 58101-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,0 and 1 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 58101-23:
(7*5)+(6*8)+(5*1)+(4*0)+(3*1)+(2*2)+(1*3)=98
98 % 10 = 8
So 58101-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H10F2O3/c1-2-16-11(15)6-10(14)8-4-3-7(12)5-9(8)13/h3-5H,2,6H2,1H3

58101-23-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-(2,4-difluorophenyl)-3-oxopropanoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58101-23-8 SDS

58101-23-8Downstream Products

58101-23-8Relevant articles and documents

Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone

Delgado, Justine L.,Lentz, Sarah R.C.,Kulkarni, Chaitanya A.,Chheda, Pratik R.,Held, Hailey A.,Hiasa, Hiroshi,Kerns, Robert J.

, p. 109 - 130 (2019/04/10)

Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones t

Synthesis and antitumor activity of novel 4-(2-fluorophenoxy)quinoline derivatives bearing the 4-Oxo-1,4-dihydroquinoline-3-carboxamide moiety

Li, Sai,Jiang, Rui,Qin, Mingze,Liu, Haicheng,Zhang, Guangyan,Gong, Ping

, p. 521 - 533 (2013/07/26)

A series of 4-(2-fluorophenoxy)quinoline derivatives bearing the 4-oxo-1,4-dihydroquinoline-3-carboxamide moiety were designed, synthesized, and evaluated for their in vitro antitumor activity against the H460, HT-29, MKN-45, U87MG, and SMMC-7721 cancer cell lines. Most of the tested compounds showed potent activity and high selectivity toward the HT-29 and MKN-45 cell lines. Furthermore, compounds 21b, 21c, and 21i were further examined for their c-Met kinase activity and exhibited strong efficacy with IC50 values in the single-digit nanomolar range, which was comparable with the positive control foretinib. The most promising compound 21c showed excellent cytostatic activity with IC50 values from 0.01 to 0.53 μM against all tested cell lines, thus being 1.7-2.2 times more active than foretinib. Novel 4-(2-fluorophenoxy)quinoline derivatives bearing the 4-oxo-1,4-dihydroquinoline- 3-carboxamide moiety were evaluated for their in vitro antitumor activity against several cancer cell lines. Compounds 21b, 21c, and 21i were also examined for their c-Met kinase activity in comparison to foretinib. Compound 21c showed excellent cytostatic activity with IC50 values from 0.01 to 0.53 μM against all tested cell lines and higher activity than foretinib.

Quinolone- and naphthyridonecarboxylic acid derivatives

-

, (2008/06/13)

The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which have hydrogen in the 6-position, to processes for their preparation, and to antibacterial compositions and feed additives containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58101-23-8